Compass Research
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Compass Research - overview
Established
2006
Location
Orlando, FL, US
Primary Industry
Biotechnology
About
Compass Research is a domain sales platform specializing in premium domain names, facilitating an efficient online marketplace for businesses and individuals seeking to enhance their digital presence through memorable web addresses. Compass Research was founded in 2006 in Orlando, US, focusing on the sale of premium domain names. The company does not report any significant pivots in its business strategy. It was acquired by Bioclinica in July 2016, a portfolio company of Water Street Healthcare Partners, JLL Partners, and Ampersand Capital Partners.
CompassResearch. com primarily operates as a domain sales platform, offering premium domain names, including its flagship domain, CompassResearch. com, for direct purchase or payment plans. The company caters to a wide range of clients such as startups and established businesses, resolving the challenge of finding relevant web addresses.
Its services allow outright purchases or flexible monthly payment options, targeting North America, Europe, and parts of Asia. The revenue model of CompassResearch. com is based on domain sales, with premium domains priced at USD 10,895, or a financing option of USD 453. 96 per month for 24 months.
The company ensures a straightforward sales process for clients and offers a 30-day money-back satisfaction guarantee. Additional services, like WhoIs Privacy Protection, are also available, contributing to a reliable revenue stream from rapid domain sales fulfillment. Compass Research is looking to expand its offerings and geographic reach. Although specific new products or services are not detailed, the company aims to enhance its marketplace capabilities.
The acquisition by Bioclinica in July 2016 signifies a strategy to leverage synergies for growth. Expansion into new markets is anticipated, targeting increased operations in North America, Europe, and selected Asian regions, although specific timelines are not provided.
Current Investors
BioClinica Inc.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.compassresearch.com
Verticals
HealthTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Compass Research - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Compass Research | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.